Moderna's Spikevax carries higher risk of myocarditis than Pfizer's Comirnaty, study says UPDATE: Flagship-founded Repertoire reveals culls, cuts and a new CEO marking dismal clinical start GSK's CAR-T Blenrep fails multiple myeloma trial, endangering its accelerated approval Life beyond COVID: BioNTech lines up five infectious disease vaccine trials for 2023 Gilead dodges Supreme Court review—and a $1.2B fine—in CAR-T patent feud with Bristol Myers Eli Lilly lines up launch of digital diabetes platform that tracks blood sugar, insulin pen use Siemens Healthineers to reduce diagnostics staff, portfolio footprint in €300M restructuring Bristol Myers' subsidiary behind cancer blockbuster Abraxane slapped with FDA warning letter Healthcare Twitter influencers beam over Pfizer's RSV shot data: report New gene therapy for epilepsy hits seizures where they start ‘The Top Line’: A recap of Fierce Biotech's Cell and Gene Therapy Forum | 